Thursday, 22 August 2019

GSK new HIV two-drug injection meets main goal in late-stage study

British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting two-drug regimen to treat HIV met the main goal of a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)